News & Updates
Inside Innovation
The latest news and advances from the world's most exciting life science cluster.

Sanofi and Seagen team up to grow a new crop of ADC cancer drugs
Seagen, a biotech company based in Bothell, Washington, is partnering up with Sanofi to develop and commercialize antibody-drug conjugates (ADCs) for up to three cancer

Washington state Department of Commerce funds 4 new ‘innovation clusters’
Washington state’s Department of Commerce has awarded $500,000 grants to four organizations forming new innovation clusters in Washington as part of the “Innovation Cluster Accelerator”

Fierce Medtech’s 2021 Fierce 15
Tasso, a Seattle-based biotech company, has been included in Fierce Medtech’s 2021 Fierce 15 list. This year’s class features innovators working to build new approaches

Life sciences roundup: A reborn institute, a long-COVID study, and responses to the war on Ukraine
As current events unfold in Ukraine, Washington state’s prosperous life science ecosystem is coming together to show its support. Several Seattle-based companies including Seagen, Silverback

Report: Seattle area still gaining tech jobs even as hubs grow elsewhere
As new tech hubs sprout up around the country, Seattle remains a top metro area for attracting tech workers. While other cities gain ground amid

DoD gives $1.1M to Seattle startup that will help find new antibodies against COVID-19 variants
A-Alpha Bio, a Seattle-based biotech company, is collaborating with Lawrence Livermore National Laboratory, to support research into new therapies for COVID-19 variants. The research is

‘Intersection of innovation’: Why top tech VC firms are betting big on life science startups
As more biotech startups are working with machine learning and computational methods to design new therapeutics and support testing, traditional tech venture capital firms such

The ‘golden age’ for research tools: Parse Biosciences raises $41.5M for single-cell tech
Parse Biosciences announced $41.5 million in funding this week. The Seattle-based biotech startup, which focuses on single-cell RNA sequencing, sets itself apart from other companies

Seattle biotech Magnolia Medical raises $46M
Magnolia Medical, a Seattle-based biotech company, raised $46 million to further propel product innovation. This financing follows a record-setting new account acquisition and top-line sales

Curevo Nets $60M for Adjuvant-Saving Shingles Vaccine
Cuervo Vaccine, a Seattle-based company, recently secured $60 million in a Series A financing round. The company, which works to develop safe and highly effective

Juno’s lasting legacy: How the cell therapy juggernaut influenced biotech in Seattle and beyond
Cell therapy company Juno Therapeutics was sold to Celgene in 2018, but its impact still reverberates throughout Seattle’s life science industry today. The company’s successes

Bristol Myers Squibb doles out $8M in new grants to improve health equity with cardiovascular, oncology focus
Bristol Myers Squibb announced its newest round of funding as part of its 2020 pledge to donate $150 million over the next five years to
